Clinical Trials Logo

Angina Pectoris clinical trials

View clinical trials related to Angina Pectoris.

Filter by:

NCT ID: NCT02845531 Recruiting - Clinical trials for Sudden Cardiac Death

Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

VARIANT ICD
Start date: November 29, 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether ICD(Implantable Cardioverter Defibrillator) implantation on the top of optimal medical therapy in patients with variant angina manifesting as aborted sudden cardiac death reduces the incidence of the death from any cause compared with optimal medical therapy alone.

NCT ID: NCT02808936 Completed - Clinical trials for Myocardial Infarction

The Effect of Remote Ischemic Preconditioning on Major Organ Function in Patients With Coronary Artery Disease Undergoing Orthopedic Surgery

RIPC-Angina
Start date: June 2016
Phase: N/A
Study type: Interventional

The investigators attempt to investigate the organ protective effect of remote ischemic conditioning in patients undergoing non-cardiac surgery with history of ischemic heart disease.

NCT ID: NCT02802046 Not yet recruiting - Angina Pectoris Clinical Trials

Evaluation of the Correlation Between the Coronary Stenosis Degree With FFRCT and the Grade of Stable Angina Pectoris

Start date: January 2017
Phase: N/A
Study type: Observational

Angina pectoris is the most common clinical manifestation of coronary heart disease(CHD), which is the main feature of chest pain caused by transient myocardial ischemia. Chronic stable angina pectoris is the degree, frequency, nature and cause of angina pectoris in patients with no significant change in a few weeks. The disease incidence is complex, difficult to diagnosis and treatment, clinical should be combined with various inspection methods for diagnosis and differential diagnosis. Fractional flow reserve of computerized tomographic scanning (FFRCT ) allows computerized tomographic scanning(CT) to scan the determination of coronary blood flow and blood pressure in the heart at rest and hyperemia, but no need to additional check or drugs. This technique has been used for noninvasive fractional flow reserve (FFR) in the calculation, assuming normal artery, calculated by the ratio of the maximum blood flow and blood flow of coronary artery stenosis of an artery. Along with the development and progress of computational fluid dynamics, in the resting state by computed tomographic angiography of coronary artery(CCTA) image data based, simulation of coronary artery maximal hyperemia and according to the 3-dimensional model of the traditional method of reconstruction of coronary arterial tree and ventricular muscle structure, and in order to calculated coronary blood flow and pressure. FFRCT is a novel non-invasive examination method, using computed tomographic angiography of coronary artery image data can be calculated FFR, and preliminary study proved that it has a high degree of correlation with traumatic FFR. Therefore, this study aims to evaluate the correlation between the degree of coronary stenosis and the grading of angina pectoris by noninvasive means --FFRCT, in order to provide a new idea for the diagnosis and differential diagnosis of coronary heart disease.

NCT ID: NCT02791087 Completed - Clinical trials for Coronary Artery Disease

Investigation of the Role of Hemodynamics in Re-stenosis of CABG Patients

Start date: June 2013
Phase:
Study type: Observational

CFD simulations in this study provide detailed hemodynamics information, which cannot be obtained from cardiac images alone. The investigators hypothesize that our proposed simulations will provide strong correlation between hemodynamic parameters, such as WSSG and SPA, and clinically identified graft stenosis. These correlations will allow the investigators to identify the future patients at high risk of graft stenosis and lead to future researches on optimizing and refining surgical plans, such as finding optimal proximal and distal anastomoses locations, optimal graft length and diameter, which could lead to improved longevity of the graft. Once CFD coupled shape optimizer is validated, it could be part of the surgical simulator to help in training the next generation physicians. It could provide new viewpoints for assessing whether some modified surgical techniques are better or not. It could also aid in designing and evaluating the vascular medical devices, including stent, artificial graft, and etc., which would lead to better surgical outcome.

NCT ID: NCT02790528 Withdrawn - Clinical trials for Angina Pectoris, Variant

Statin Therapy In Patients With Vasospastic Angina

STAVA
Start date: July 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.

NCT ID: NCT02776657 Completed - Clinical trials for Myocardial Infarction

Intracoronary Thrombus Detection by Magnetic Resonance Imaging

Start date: January 14, 2016
Phase: N/A
Study type: Interventional

This study involves the use of Magnetic Resonance Imaging (MRI) to determine whether blood clots can be identified within the blood vessels supplying blood to the heart in patients with angina and who have recently suffered a heart attack.

NCT ID: NCT02773615 Recruiting - Angina Pectoris Clinical Trials

CT Perfusion Added to CT Angiography

PERFeCT
Start date: September 28, 2017
Phase:
Study type: Observational [Patient Registry]

Background In the differential diagnosis of unstable angina versus non-anginal chest pain, an exercise test is often the modality of choice for further investigation. However, in a substantial number of patients exercise testing is less informative, because of insufficient exercise capacity or pre-existing ECG-abnormalities. In patients with low pretest probability of coronary artery disease (CAD), Coronary CT angiography (CTA) has an excellent negative predictive value, but in patients with an intermediate or high pretest probability of CAD estimation of the hemodynamic significance of a stenosis has only limited specificity. CT perfusion (CTP) is a new method looking at myocardial perfusion during vasodilative stress with a sensitivity, specificity, positive predictive value and negative predictive value of respectively 81%, 93%, 87% and 88%, whereas radiation is limited to a maximum of 5 millisievert (mSv). Aim It is the aim of this pilot study to investigate whether the addition of CTP to CTA is a feasible and safe investigational workflow in patients with unstable angina or nonanginal chest pain in the emergency department.

NCT ID: NCT02760732 Recruiting - Angina, Unstable Clinical Trials

Drug Eluting Balloon for Treatment of Unstable Angina

Start date: November 2015
Phase: N/A
Study type: Interventional

This study was to investigate the effect and safety of drug eluting balloon combined for treatment of unstable angina.

NCT ID: NCT02758912 Completed - Angina Pectoris Clinical Trials

Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers

Start date: November 2016
Phase: Phase 4
Study type: Interventional

The objective of this study is to evaluate the long-term plasma and urine pharmacokinetic parameters of Cardionat®, capsules 250 mg, when used in healthy athlete volunteers. The study consists of four steps: - Step 1. Screening - selecting healthy volunteers for inclusion in the study; - Step 2. Assignment in one of the study group, prescription of the study drug; - Step 3. Samples collections for pharmacokinetic analysis; - Step 4. Evaluation of pharmacokinetic data.

NCT ID: NCT02747329 Completed - Clinical trials for Coronary Artery Disease

A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT

Start date: June 15, 2016
Phase: N/A
Study type: Interventional

The objective of this study is a comparative evaluation of BuMA Supreme™ stent and of Xience V/Prime stent in terms of the extent of neointima formation at 1 or 2 months after implanting in relatively high bleeding risk patients with coronary artery disease using OCT.